<乌鸦传媒>Big Win in Psoriasis for Dual IL-17A/17F Inhibitor Significant differences in clearance with bimekizumab vs secukinumab at all time points Apr 23, 2021
<乌鸦传媒>For Enthesitis in Psoriatic Arthritis, Target IL-23 Targeted agent provides relief for many PsA patients Apr 08, 2021
<乌鸦传媒>JAK Inhibitor Promising in Psoriatic Arthritis Oral agent noninferior to adalimumab in joint symptoms Apr 01, 2021
<乌鸦传媒>Don't Stop Taltz in Psoriatic Arthritis Significantly more patients relapsed, and more quickly, after withdrawal Mar 10, 2021
<乌鸦传媒>Monoclonal Antibody Highly Effective in Phase III Psoriasis Trial Beats ustekinumab, but main side effect was oral candidiasis Feb 05, 2021
<乌鸦传媒>TYK2 Inhibition Promising in Psoriatic Arthritis Phase II study found significant benefits for two doses of novel agent Nov 10, 2020
<乌鸦传媒>Gut Bacteria for Psoriasis; Long-Term Hair Growth; COVID and STDs Selected presentations from the European Academy of Dermatology and Venereology virtual conference Nov 05, 2020
<乌鸦传媒>Nonsteroidal Topical, Nanodrug Active in Psoriasis Selected presentations from the European Academy of Dermatology and Venereology meeting Nov 04, 2020
<乌鸦传媒>Targeting IL-23 Relieves Multiple Symptoms in PsA Both enthesitis and dactylitis improved with guselkumab treatment in psoriatic arthritis Jul 21, 2020
<乌鸦传媒>Psoriasis Cream Succeeds in Early Trial PDE-4 inhibitor helped clear plaque psoriasis in 6 weeks Jul 15, 2020
<乌鸦传媒>Psoriatic Arthritis: Outcomes Similar for Cosentyx and Humira Primary endpoint of superiority for secukinumab over adalimumab not met in a phase IIIb trial Jun 08, 2020
<乌鸦传媒>EULAR 2020: What to Expect Cancelled due to pandemic but extensive menu of virtual learning planned Jun 02, 2020
<乌鸦传媒>Biologics Don't Increase Melanoma Risk... Probably Meta-analysis offers some reassurance, but leaves room for doubt May 20, 2020
<乌鸦传媒>Guselkumab a Hit in Phase III for PsA Primary endpoints met in two large trials in psoriatic arthritis for IL-23 inhibitor Apr 10, 2020
<乌鸦传媒>Psoriasis IL-23 Biologic Maintains Efficacy in 2-Year Trial Phase III trial looked at risankizumab (Skyrizi) Apr 08, 2020
<乌鸦传媒>IL-31 Drug Succeeds for Prurigo Nodularis Less itching and twice as many lesions resolved with investigational agent Feb 19, 2020
<乌鸦传媒>Confirmed: TNF Inhibitors Don't Raise Cancer Risk Reassurance from national study in Denmark Dec 13, 2019
<乌鸦传媒>Reassurance on Live-Virus Shingles Vax With Anti-TNFs Randomized trial indicates fears of infection unfounded Nov 11, 2019
<乌鸦传媒>Psoriasis Model: Ketogenic Diets' Effects Not Equal Some fats affect the skin more than others, preclinical study suggests Nov 05, 2019
<乌鸦传媒>Got Psoriasis? Maybe Best to Avoid Certain Keto Diets Animal study suggests the two don't always play together nicely Oct 22, 2019
<乌鸦传媒>JAK Inhibitors Emerging as Oral Option for Psoriasis But older oral therapies remain key therapeutic players for many patients Oct 22, 2019
<乌鸦传媒>Chronic Itch: New Therapy, Complexities "End of the antihistamine era" as new strategies target neural mechanisms Oct 18, 2019
<乌鸦传媒>Can Anti-TNF Drugs Reduce Alzheimer's Risk? Analysis of 56 million patients hints at possible connections Oct 04, 2019
<乌鸦传媒>Kim Kardashian West鈥檚 Mystery Illness Revealed Rheumatologists may have already guessed Sep 19, 2019
<乌鸦传媒>IL-17a Drug Rescues Many Refractory Psoriatic Arthritis Cases Disease abated in half of patients receiving secukinumab after failing other biologics Jun 14, 2019
<乌鸦传媒>No Cancer Risk Found With TNF Inhibitors in Psoriatic Arthritis Expected cancer cases similar to those in general populace, study shows Jun 13, 2019
<乌鸦传媒>Cosentyx Safety Confirmed Through 5 Years Safety profile favorable in psoriasis, psoriatic arthritis, and ankylosing spondylitis May 04, 2019
<乌鸦传媒>Vitiligo, Alopecia Merely Cosmetic? Think Again Studies show links with depression, quality of life -- and early death Apr 18, 2019
<乌鸦传媒>Bone Marrow Transplant for Autoimmune Disease: Ready for Prime Time? Everything you know about BMT is probably wrong, says hematologist Apr 08, 2019
<乌鸦传媒>When Not to Use Biologics for Psoriasis Comorbidities, special populations, idiosyncrasies influence decisions Mar 06, 2019
<乌鸦传媒>IBD Rates Low in Patients on Cosentyx Analysis of data from 21 clinical trials in psoriasis, psoriatic arthritis, and ankylosing spondylitis Jan 25, 2019
<乌鸦传媒>Two-Drug Regimen Fails to Stem Psoriasis Relapse Study looks at costimulatory blockade with abatacept after stopping ustekinumab Dec 18, 2018
<乌鸦传媒>Skin Lesions Linked With Anti-TNF in IBD Most paradoxical psoriasiform eruptions were managed locally Dec 17, 2018
<乌鸦传媒>Skin-Stripping Test Promising for Inflammatory Skin Diseases Protein analysis may help differentiate between eczema, psoriasis Dec 16, 2018
<乌鸦传媒>PASDAS: Targeting Multiple Aspects of PsA Secukinumab showed efficacy for the various domains of psoriatic arthritis Dec 10, 2018
<乌鸦传媒>In Psoriatic Arthritis, Doubling Down on IL-17 Bimekizumab targets both IL-17A and F; "astonishing" results in psoriatic arthritis Oct 25, 2018
<乌鸦传媒>Psoriasis Response Falls as Comorbidities Rise Comorbid conditions reported in two-thirds of patients Sep 14, 2018
<乌鸦传媒>Minimal Disease Activity: The Goal in PsA Validity confirmed in large population of patients Jul 19, 2018
<乌鸦传媒>Enthesitis in PsA: A New Focus of Treatment? Targeting IL-23 with ustekinumab cleared enthesitis in three-quarters of patients Jun 22, 2018
